VistaGen Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS).
Vistagen Therapeutics stock last closed at $2.10, down 0.47% from the previous day, and has decreased 56.07% in one year. It has overperformed other stocks in the Biotechnology industry by 0.21 percentage points. Vistagen Therapeutics stock is currently +10.53% from its 52-week low of $1.90, and -58% from its 52-week high of $5.00.
As of Apr 21, 2025, there are 28.86M VTGN shares outstanding. The market cap of VTGN is $60.61M. In the past 24 hours, 103,243 VTGN shares were traded.
How to Buy Vistagen Therapeutics Stock
Not sure how to invest in Vistagen Therapeutics stock? Here's how.
Decide where to buy Vistagen Therapeutics stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you choose where to buy Vistagen Therapeutics stock.
Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Select your payment method and add your details.
Analyze Vistagen Therapeutics stock: The Vistagen Therapeutics ticker symbol is VTGN. Is Vistagen Therapeutics stock a good investment? Should you buy shares of VTGN? How do VTGN's underlying business fundamentals look? Do top analysts think Vistagen Therapeutics is a good buy? Why has VTGN's stock price moved recently? (Hint: Our stock research tools can help you decide if VTGN is a good stock to buy).
Make your VTGN purchase: Decide if you will purchase VTGN shares at the current market price or use a limit order to purchase VTGN shares at a particular price.
Monitor your investment in VTGN: Create a watchlist to track your new investment in Vistagen Therapeutics shares.
Step 1: Decide where to buy Vistagen Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy VTGN stock.
A brokerage account allows you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to global financial markets: From Technology to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've picked your brokerage, you need to fill out some personal info so you are able to invest in VTGN stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Vistagen Therapeutics stock
Once you have chosen the best place to buy Vistagen Therapeutics stock, it's very important to evaluate their stock prior to investing, so you truly wrap your head around the risk and opportunity.
Vistagen Therapeutics shares quick numbers
VTGN Price
$2.10
1w %
-5.83%
1y %
-56.07%
5y %
-82.93%
P/E
-1.42x
P/B
0.75x
P/S
91.3x
PEG
N/A
Revenue
$698.30k
Earnings
-$47.30M
Fore. Rev. Growth
210.47%
Fore. Earn. Growth
N/A
Market Cap
$60.61M
Next Earnings
N/A
Next Dividend
N/A
VTGN Fundamentals
WallStreetZen was created to help average investors do better fundamental analysis in minutes instead of hours.
Last year, VTGN revenue was $698.30k. During the past four year, VTGN's revenue has grown by 1.9% per year. This was slower than the Biotechnology industry average of 44.31%.
Are VTGN executives and large shareholders buying or selling the stock?
In the past 12 months, insiders at VTGN have bought more shares than they have sold.
Cynthia Lynn Anderson, CHIEF FINANCIAL OFFICER of VTGN, was the latest VTGN insider to buy. They bought $6,498.14 worth of VTGN shares on Dec 31, 2024.
No, Vistagen Therapeutics doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your VTGN purchase
There are two primary options:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are usually the easiest way to buy.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at an exact price, use a limit order.
Click the Open Trade button and eToro will place your order.
If you need more help buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Vistagen Therapeutics share?
As of Apr 21, 2025, it costs $2.10 to buy one share of Vistagen Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.476 shares of VTGN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.